Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIH

Journal of Hepatology

Volumn 56, Issue 4, 2012, Pages 862-868

  Salmon, Dominique ^a   Bani Sadr, Firouzé ^a   Loko, Marc Arthur ^b   Stitou, Hind ^c   Gervais, Anne ^d   Durant, Jacques ^e   Rosenthal, Eric ^e   Quertainmont, Yann ^f   Barange, Karl ^g   Vittecoq, Daniel ^h   Shoai Tehrani, Michka ⁱ   Alvarez, Muriel ^g   Winnock, Maria ^b   Trinchet, Jean Claude ^j   Dabis, Franois ^b   Sogni, Philippe ^a  

^a Université Paris Descartes ^*  (France)

^b INSERM   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f BICÊTRE HOSPITAL   (France)

^g CHU PURPAN   (France)

^h HÔPITAL PAUL BROUSSE   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j HÔPITAL JEAN VERDIER   (France)

more..

Author keywords

Hepatocellular carcinoma; HIV HCV co infection; Insulin resistance

Indexed keywords

ALPHA FETOPROTEIN; PROTHROMBIN;

ADULT; ARTICLE; CANCER RISK; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUPERINFECTION; THROMBOCYTE COUNT;

ADULT; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; INSULIN RESISTANCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84858703326     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.11.009     Document Type: Article

References (38)

1. M.S. Sulkowski, S.H. Mehta, M.S. Torbenson, Y. Higgins, S.C. Brinkley, and R.M. de Oca Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults AIDS 21 2007 2209 2216 (Pubitemid 350287219)
2. F. Bani-Sadr, N. Lapidus, P. Bedossa, C.M. De Boever, C. Perronne, and P. Halfon Progression of fibrosis in HIV and hepatitis C virus-co-infected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors Clin Infect Dis 46 2008 768 774 (Pubitemid 351321564)
3. N. Brau, M. Salvatore, C.F. Rios-Bedoya, A. Fernandez-Carbia, F. Paronetto, and J.F. Rodriguez-Orengo Slower fibrosis progression in HIV/HCV-co-infected patients with successful HIV suppression using antiretroviral therapy J Hepatol 44 2006 47 55 (Pubitemid 41772515)
4. F. Bani-Sadr, F. Carrat, P. Bedossa, L. Piroth, P. Cacoub, and C. Perronne Hepatic steatosis in HIV-HCV co-infected patients: analysis of risk factors AIDS 20 2006 525 531 (Pubitemid 43731596)
5. F. Blanco, P. Barreiro, P. Ryan, E. Vispo, L. Martin-Carbonero, and P. Tuma Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance J Viral Hepat 18 2011 11 16
6. F. Bani-Sadr, P. Bedossa, E. Rosenthal, D. Merrien, P. Perre, and C. Lascoux-Combe Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-co-infected patients? J Acquir Immune Defic Syndr 50 2009 234 236
7. N. Merchante, I. Perez-Camacho, J.A. Mira, A. Rivero, J. Macias, and A. Camacho Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis co-infection: role of didanosine Antivir Ther 15 2010 753 763
8. M. Sulkowski Hepatocellular carcinoma in HIV-infected patients comes of age: the convergence of epidemiology and treatment effectiveness J Hepatol 50 2009 655 658
9. D. Salmon-Ceron, E. Rosenthal, C. Lewden, V. Bouteloup, T. May, and C. Burty Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: the French national Mortalite 2005 study J Hepatol 50 2009 736 745
10. N. Brau, R.K. Fox, P. Xiao, K. Marks, Z. Naqvi, and L.E. Taylor Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study J Hepatol 47 2007 527 537 (Pubitemid 47334759)
11. M.A. Loko, D. Salmon, P. Carrieri, M. Winnock, M. Mora, and L. Merchadou The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010 BMC Infect Dis 10 2010 303
12. L. Castera, X. Forns, and A. Alberti Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 48 2008 835 847
13. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430 (Pubitemid 32844200)
14. J.F. Ascaso, P. Romero, J.T. Real, A. Priego, C. Valdecabres, and R. Carmena Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population Med Clin (Barc) 117 2001 530 533 (Pubitemid 33100193)
15. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
16. P. Ryan, F. Blanco, P. Garcia-Gasco, J. Garcia-Merchan, E. Vispo, and P. Barreiro Predictors of severe hepatic steatosis using abdominal ultrasound in HIV-infected patients HIV Med 10 2009 53 59
17. N. Merchante, A. Rivero, I. de Los Santos-Gil, D. Merino, M. Marquez, and M.A. Lopez-Ruz Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients Gut 58 2009 1654 1660
18. P.C. Tien, M.F. Schneider, S.R. Cole, A.M. Levine, M. Cohen, and J. Dehovitz Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV Study J Acquir Immune Defic Syndr 2008
19. S. De Wit, C.A. Sabin, R. Weber, S.W. Worm, P. Reiss, and C. Cazanave Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study Diabetes Care 31 2008 1224 1229
20. R. Moucari, T. Asselah, D. Cazals-Hatem, H. Voitot, N. Boyer, and M.P. Ripault Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis Gastroenterology 134 2008 416 423 (Pubitemid 351181308)
21. J.A. Pineda, J. Gonzalez, E. Ortega, C. Tural, J. Macias, and L. Griffa Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-co-infected patients J Viral Hepat 17 2010 714 719
22. B.J. Veldt, W. Chen, E.J. Heathcote, H. Wedemeyer, J. Reichen, and W.P. Hofmann Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus Hepatology 47 2008 1856 1862 (Pubitemid 351945553)
23. K. Mondy, E.T. Overton, J. Grubb, S. Tong, W. Seyfried, and W. Powderly Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population Clin Infect Dis 44 2007 726 734
24. M.M. Hassan, S.A. Curley, D. Li, A. Kaseb, M. Davila, and E.K. Abdalla Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma Cancer 116 2010 1938 1946
25. Y. Kawamura, Y. Arase, K. Ikeda, M. Hirakawa, T. Hosaka, and M. Kobayashi Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients Am J Med 123 2010 951 956 e951
26. C.H. Hung, J.H. Wang, T.H. Hu, C.H. Chen, K.C. Chang, and Y.H. Yen Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection World J Gastroenterol 16 2010 2265 2271
27. M. Sherman Hepatocellular carcinoma: new and emerging risks Dig Liver Dis 42 2010 S215 S222
28. G. Nkontchou, J.P. Bastard, M. Ziol, M. Aout, E. Cosson, and N. Ganne-Carrie Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis J Hepatol 53 2010 827 833
29. T.M. Welzel, B.I. Graubard, S. Zeuzem, H.B. El-Serag, J.A. Davila, and K.A. McGlynn Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database Hepatology 54 2011 463 471
30. V. Paradis, S. Zalinski, E. Chelbi, N. Guedj, F. Degos, and V. Vilgrain Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis Hepatology 49 2009 851 859
31. J.R. Pekow, A.K. Bhan, H. Zheng, and R.T. Chung Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis Cancer 109 2007 2490 2496 (Pubitemid 46908652)
32. K. Ohata, K. Hamasaki, K. Toriyama, K. Matsumoto, A. Saeki, and K. Yanagi Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection Cancer 97 2003 3036 3043 (Pubitemid 36676258)
33. S. Petta, C. Camma, V. Di Marco, N. Alessi, D. Cabibi, and R. Caldarella Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection Am J Gastroenterol 103 2008 1136 1144 (Pubitemid 351677995)
34. M. Guiguet, F. Boue, J. Cadranel, J.M. Lang, E. Rosenthal, and D. Costagliola Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study Lancet Oncol 10 2009 1152 1159
35. G.M. Clifford, M. Rickenbach, J. Polesel, L. Dal Maso, I. Steffen, and B. Ledergerber Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma AIDS 22 2008 2135 2141
36. M. Bruyand, F. Dabis, M.A. Vandenhende, E. Lazaro, D. Neau, and O. Leleux HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008 J Hepatol 55 2011 1058 1062
37. B.H. McGovern, Y. Golan, M. Lopez, D. Pratt, A. Lawton, and G. Moore The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients Clin Infect Dis 44 2007 431 437 (Pubitemid 46147629)
38. R. Anaparthy, J.A. Talwalkar, M. Yin, L.R. Roberts, J.L. Fidler, and R.L. Ehman Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis Aliment Pharmacol Ther 2011